In recent trading session, Elevance Health Inc (NYSE:ELV) saw 0.8 million shares changing hands at last check today with its beta currently measuring 0.61. Company’s recent per share price level of $362.46 trading at -$11.83 or -3.16% at last check today assigns it a market valuation of $81.89B. That most recent trading price of ELV’s stock is at a discount of -56.5% from its 52-week high price of $567.26 and is indicating a premium of 0.07% from its 52-week low price of $362.21. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.51 million shares which gives us an average trading volume of 1.72 million if we extend that period to 3-months.
For Elevance Health Inc (ELV), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.71. Splitting up the data highlights that, out of 12 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Elevance Health Inc (NYSE:ELV) trade information
Upright in the red during last session for losing -3.16%, in the last five days ELV remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $362.46 price level, adding 14.56% to its value on the day. Elevance Health Inc’s shares saw a change of -1.74% in year-to-date performance and have moved -12.10% in past 5-day. Elevance Health Inc (NYSE:ELV) showed a performance of -17.20% in past 30-days. Number of shares sold short was 2.68 million shares which calculate 1.38 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 465 to the stock, which implies a rise of 22.05% to its recent value today. Analysts have been projecting 465 as a low price target for the stock while placing it at a high target of 465. It follows that stock’s current price would drop -28.29% in reaching the projected high whereas dropping to the targeted low would mean a loss of -28.29% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 6.81% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 4.44% while estimates for its earnings growth in next 5 years are of 10.64%.
ELV Dividends
Elevance Health Inc is more likely to be releasing its next quarterly report on 2025-Apr-21 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 1.82%, the share has a forward dividend of 6.60 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 1.18%.
Elevance Health Inc (NYSE:ELV)’s Major holders
Insiders are in possession of 0.17% of company’s total shares while institution are holding 94.72 percent of that, with stock having share float percentage of 94.88%. Investors also watch the number of corporate investors in a company very closely, which is 94.72% institutions for Elevance Health Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at ELV for having 21.21 million shares of worth $11.49 billion. And as of 2024-06-30, it was holding 9.133 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 20.7 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.9168 of outstanding shares, having a total worth of $11.22 billion.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 7.27 shares of worth $2.65 billion or 3.22% of the total outstanding shares. The later fund manager was in possession of 6.28 shares on Dec 31, 2024 , making its stake of worth around $2.29 billion in the company or a holder of 2.78% of company’s stock.
